20:19 , Dec 15, 2016 |  BC Innovations  |  Translation in Brief

Fore score

Cerecor Inc. (NASDAQ:CERC) has picked up a forebrain-selective anti-epileptic compound from Eli Lilly and Co. (NYSE:LLY) that could treat seizures by blocking AMPA glutamate receptor (GRIA; GLUR) without the dose-limiting motor side effects associated with...
07:00 , Oct 10, 2016 |  BC Week In Review  |  Company News

Eli Lilly, Cerecor deal

Eli Lilly granted Cerecor exclusive, worldwide rights to develop and commercialize CERC-611 (formerly LY3130418). Cerecor expects to begin Phase I testing of the transmembrane AMPAR regulatory protein gamma-8 ( TARP gamma-8; CACNG8)-dependent ...